New Technology, Drug-eluting Resorbable Scaffold
- New Codes (Valid for October 1, 2024 discharges)
- New Technology: Esprit™ BTK Everolimus Eluting Resorbable Scaffold System
Esprit is designed to physically support the vessel and release everolimus to reduce the risk of re-narrowing.Over three years, the scaffold is resorbed to allow vessel remodeling and reduce the chances of late complications. The FDA approved the device because the resorbable scaffold has a lower rate of vessel re-narrowing than balloon angioplasty in chronic limb-threatening ischemia (CLTI).
New Codes:
Looking for Coding help?
e4health Coding Education
e4health is dedicated to elevating the business of healthcare. We are committed to offering support and the most current information and updates to collaborate with coding and CDI professionals to realize their fullest potential. We enthusiastically seek opportunities to develop ourselves and each other. We understand that knowledge is the key to success for our clients navigating the ever-changing health information management landscape.
The information and opinions presented here are based on the experience, training, and interpretation of e4health. Although the information has been researched and reviewed for accuracy, e4health does not accept any responsibility or liability regarding errors, omissions, misuse, or misinterpretation. This information is intended as a guide; it should not be considered a legal/consulting opinion or advice.